AbbVie announced another round of 85 layoffs at its Irvine, California site tied to eye-care activities, according to a WARN notice effective July 20. The move follows prior headcount reductions at the former Allergan footprint after AbbVie’s 2019 acquisition and comes as the company navigates competitive pressure in Botox and broader aesthetics-related portfolios.